Article

Pharmacy Clinical Pearl of the Day: Hodgkin Lymphoma

Hodgkin lymphoma is most common in people between 20 and 40 years of age and those over 55 years of age.

Clinical Pearl of the Day: Hodgkin Lymphoma

Hodgkin lymphoma is a cancer of the lymphatic system, which is part of the immune system.

Insight:

  • Hodgkin lymphoma may affect people of any age but is most common in people between 20 and 40 years of age and those over 55 years of age.
  • Symptoms include painless swelling of lymph nodes in the neck, armpits or groin, persistent fatigue, fever, night sweats, unexplained weight loss, severe itching, and increased sensitivity to alcohol or pain.
  • Subtypes of classical Hodgkin lymphoma include nodular sclerosis Hodgkin lymphoma, mixed cellularity Hodgkin lymphoma, lymphocyte-depleted Hodgkin lymphoma, and lymphocyte-rich Hodgkin lymphoma.
  • Risk factors include age between 15 to 30 years and over 55 years, family history of lymphoma, being male, and past Epstein-Barr infection
  • Diagnosis includes physical exam, blood tests, imaging tests, removing the lymph node for testing and removing a sample of bone marrow for testing
  • Treatment includes chemotherapy, radiation therapy and bone marrow transplant
  • Chemotherapy options include:

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
© 2025 MJH Life Sciences

All rights reserved.